Statistics
Publications
9
Citations
16.9K
H-Index
9
Active since
2015
Holly Kemberling is an author at Sidney Kimmel Comprehensive Cancer Center specializing in cancer immunotherapy, immune checkpoint inhibitors, and checkpoint inhibitor therapy.
Publications per year
2015–2023
9
9
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · New England Journal of Medicine · 2015 · 9.4K citations · Full text
Life Sciences, Immunology, Oncology +17
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith et al. · Science · 2017 · 6.6K citations
Life Sciences, Immunology, Oncology +17
PD-1 blockade in tumors with mismatch repair deficiency.
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · Journal of Clinical Oncology · 2015 · 553 citations
Medicine, Cancer Biology, Oncology +12
Programmed death-1 blockade in mismatch repair deficient colorectal cancer.
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · Journal of Clinical Oncology · 2016 · 107 citations
Life Sciences, Immunology, Oncology +17
PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
Dung T. Le, Jennifer N. Uram, Hao Wang et al. · Journal of Clinical Oncology · 2016 · 63 citations
Medicine, Oncology, Pharmacology +17
1–5 of 9